Previous 10 | Next 10 |
MORRISVILLE, N.C., Oct. 21, 2022 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2022 financial results on Friday, November 4, 2022, prior to its earnings call at 8:00 a.m. ET. ...
The shares of Syneos Health ( NASDAQ: SYNH ) traded lower in the pre-market Tuesday JPMorgan downgraded the Contract Research Organization to Neutral from Overweight, citing uncertainty over the company's revenue outlook. The analysts led by Casey Woodring attributed the dec...
MORRISVILLE, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of William E. Klitgaard to its Board of Directors. Mr. Klitgaard was previously a member of the S...
MORRISVILLE, N.C., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has been awarded a Triangle Business Journal 2022 Leaders in Diversity Award for notable accomplishments in the...
Syneos Health ( NASDAQ: SYNH ) said it expanded its partnership with Datavant to accelerate delivery of new therapies to patients. Syneos will use Datavant Switchboard to develop advanced analytics and AI-driven technologies to execute more efficient clinical trials, t...
MORRISVILLE, N.C., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced an expanded partnership with Datavant, the leader in helping organizations securely connect health data. The incre...
MORRISVILLE, N.C., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2021 Sustainability Report. The Report spotlights how the Company and its more than 29,000 employees have acted...
Summary A high level of restructuring is occurring with the Healthcare industry’s largest constituents. Most restructuring is taking the form of splits or spin-offs, but not all incidences look beneficial. This article will summarize coming transactions and provide comm...
Summary Southeastern’s 13F portfolio value decreased from $5.66B to $4.74B this quarter. The number of positions increased from 35 to 36. They increased IAC/Interactive, Hyatt Hotels, General Electric, Warner Bros. Discovery, and Liberty Broadband and Affiliated Managers Gr...
The shares of contract research organization Syneos Health, Inc. ( NASDAQ: SYNH ) dropped ~13% in the morning hours Tuesday after the company projected its Book-to-Bill ratio in the Clinical Solutions business could reach 1.05x – 1.15x for the 12-months ending Sep. ...
News, Short Squeeze, Breakout and More Instantly...
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. PR Newswire JERSEY CITY, N.J. , April 29, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is celebrating its eight-year anniversary of being established in th...
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting PR Newswire Presentations span Parkinson's disease and ALS clinical and real-world evidence Oral platform sessions will highlight r...
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) PR Newswire Orphan Drug Exclusivity recognized for RADICAVA ORS based on major contribution to patient care JERSEY CITY, N.J. ...